KED- Kidney Health Evaluation for Patients with Diabetes

Product Lines:
Advantage MD, EHP, Priority Partners, and USFHP.

Eligible Population:
Members 18 and 85 years of age as of December 31 of the measurement year.

Definition:
Percentage of members 18–85 years of age with diabetes (type 1 and type 2) as of December 31 of the measurement year  who received a kidney health evaluation, defined by an estimated glomerular filtration rate (eGFR) and a urine albumin-creatinine ratio (uACR), during the measurement year.

Reports three age stratifications and a total rate:

  • 18-64
  • 65-75
  • 76-85
  • Total. The total is the sum of the age stratifications.

New for Measure: Stratification by race and ethnicity.

Continuous Enrollment:

  • The measurement year.

Best Practice and Measure Tips

  • Requires both an eGFR and a uACR during the measurement year on the same or different dates of service:
    • Routinely refer members with a diagnosis of diabetes for both eGFR and uACR.  A quantitative urine albumin test and a urine creatinine test require service dates four or less days apart.
  • Follow up with patients to discuss and educate on lab results
  • Educate on how diabetes can affect the kidneys and offer tips to your patients on preventing damage to their kidneys
  • Controlling their blood pressure, blood sugars, cholesterol, and lipid levels
  • Take medications as prescribed that can protect kidney function (ACE inhibitors or ARBs)
  • Offer education on medications that could be harmful to the kidneys (NSAIDs such as naproxen or ibuprofen)
  • Limit protein intake and salt in diet
  • Coordinate care with specialists such as an endocrinologist or nephrologist as needed.

Measure Exclusions

Required Exclusions:

  • ESRD 
  • Dialysis
  • Palliative Care
  • Members in hospice or using hospice services anytime during the measurement year.
  • Members who died any time during the measurement year.
  • Frailty
  • Frailty and Advanced Illness
  • Living in Long Term Care     

Measure Codes

There is a large list of approved NCQA codes used to identify the services included in the KED measure. The following are just a few of the approved codes.

  • Estimated Glomerular Filtration Rate Lab Test
    • CPT: 80047, 80048, 80050, 80053, 80069, 82565
  • Quantitative Urine Albumin Lab Test
    • CPT: 82043
    • LOINC: 100158-5, 14957-5, 1754-1, 21059-1, 30003-8, 43605-5, 53530-2, 53531-0, 57369-1, 89999-7
  • Urine Albumin Creatinine Ratio (uACR) Lab Test
    • LOINC: 13705-9, 14958-3, 14959-1, 30000-4, 44292-1, 59159-4, 76401-9, 77253-3, 77254-1, 89998-9, 9318-7
  • Urine Creatinine Lab Test
    • CPT: 82570
    • LOINC: 20624-3, 2161-8, 35674-1, 39982-4, 57344-4, 57346-9, 58951-5

Medication List: Diabetes Medications

Prescription Medication Lists
Alpha-glucosidase inhibitors
  • Acarbose
  • Miglitol
Amylin analogs
  • Pramlintide
Antidiabetic combinations
  • Alogliptin-metformin 
  • Alogliptin-pioglitazone
  • Canagliflozin-metformin
  • Dapagliflozin-metformin
  • Dapagliflozin-saxagliptin
  • Empagliflozin-linagliptin
  • Empagliflozin-metformin
  • Empagliflozin-linagliptin-metformin
  • Ertugliflozin-metformin
  • Ertugliflozin-sitagliptin
  • Glimepiride-pioglitazone
  • Glipizide-metformin
  • Glyburide-metformin
  • Linagliptin-metformin 
  • Metformin-pioglitazone
  • Metformin-repaglinide
  • Metformin-rosiglitazone
  • Metformin-saxagliptin
  • Metformin-sitagliptin
Insulin
  • Insulin aspart 
  • Insulin aspart-insulin aspart protamine
  • Insulin degludec 
  • Insulin degludec-liraglutide
  • Insulin detemir
  • Insulin glargine
  • Insulin glargine-lixisenatide 
  • Insulin glulisine 
  • Insulin isophane human
  • Insulin isophane-insulin regular
  • Insulin lispro
  • Insulin lispro-insulin lispro protamine 
  • Insulin regular human
  • Insulin human inhaled
Meglitinides
  • Nateglinide    
  • Repaglinide
 Biguanides
  •  Metformin
Glucagon-like peptide-1 (GLP1) agonists
  • Albiglutide 
  • Dulaglutide 
  • Exenatide    
  • Liraglutide
  • Lixisenatide
  • Semaglutide
Sodium glucose cotransporter 2 (SGLT2) inhibitor
  • Canagliflozin  
  • Dapagliflozin  
  • Empagliflozin
  • Ertugliflozin
Sulfonylureas
  • Chlorpropamide
  • Glimepiride  
  •  Glipizide
  • Glyburide  
  • Tolazamide 
  • Tolbutamide
Thiazolidinediones
  • Pioglitazone    
  • Rosiglitazone
Dipeptidyl peptidase-4 (DDP-4) inhibitors
  • Alogliptin   
  • Linagliptin    
  • Saxagliptin
  • Sitagliptin